Finance

Beta
Lists
NIRV.X:CNSX
Nirvana Life Sciences Inc
CA$0.050
0.00%
(0.00) 1D
Jun 24, 11:10:15 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NIRV.X...
Mkt. cap
1.14M
Avg. vol.
597.00
Volume
0.00
52-wk high
CA$0.05
52-wk low
CA$0.00
EPS
-CA$0.04
No. of employees
2
Mkt. cap
1.14M
Avg. vol.
597.00
Volume
0.00
52-wk high
CA$0.05
52-wk low
CA$0.00
EPS
-CA$0.04
No. of employees
2
News stories
From sources across the web
About Nirvana Life Sciences Inc
CEO-
Employees2
Founded2011
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitenirvanalifescience.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155.51K
45.86K
79.99K
47.90K
Operating expense
158.42K
45.86K
79.99K
47.90K
Total operating expenses
158.42K
45.86K
79.99K
47.90K
Operating income
-158.42K
-45.86K
-79.99K
-47.90K
Other non operating income
-10.94K
-4.56K
-10.85K
-3.65K
EBT including unusual items
-169.36K
-36.42K
-90.84K
-53.55K
EBT excluding unusual items
-169.36K
-50.42K
-90.84K
-53.55K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-170.05K
-36.41K
-90.84K
-53.24K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-2.00K
Net interest expenses
-
-
-
-2.00K
Depreciation and amortization charges
-12.21K
-
-
-
EBITDA
-153.84K
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer